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Hemodynamic stabilityAbstract Background: Pediatric cardiac anesthesia involves anaesthetizing very small children
with complex congenital heart disease. Sevoflurane provides the advantage of rapid induction of
anesthesia with short recovery time. Ketofol is a neologism coined to refer to the combination of
ketamine and propofol mixed together in one syringe. Ketamine and propofol have opposing
influences on blood pressure, heart rate, and SVR.
Aim of the work: To compare the effectiveness and side effects of ketofol versus sevoflurane for
maintenance of aesthesia in pediatric cardiac catheterization.
Methods: This double blinded randomized study was carried on 90 pediatric patients ASA II and III
undergoing cardiac catheterization. Induction was accomplished with titration of 3–5% sevoflurane.
Patients were randomly assigned to one of the two study groups. Group K received ketofol mixture
(propofol, 4 mg/mL, and ketamine, 2 mg/mL) infusion rate propofol 25–50 mic/kg/min and keta-
mine 12.5–25 mic/kg/min for maintenance. Group S received sevoflurane 0.5–1 MAC. Changes in
recovery time, hemodynamic variables and the incidence of adverse effects were measured.
Results: Diastolic blood pressure showed significant difference between the study groups at induc-
tion p (0.001), 5 min after induction p(0.04), on recovery 0.037, 5 min postoperatively p(0.016), and
10 min postoperatively. The need for vasopressor andMAP decrease >20% compared with baseline
did not show significant difference p(0.832). Recovery time was shorter in group S p(.000). The
incidence of nausea and vomiting was significantly more in group S p(.000). Emergence agitation
was observed in group S in 12(26.6) patients. Watcha scale was significantly lower in group K at
10 min postoperatively p(.001).
Conclusions: Both propofol–ketamine and sevoflurane provided effective sedation and analgesia
during pediatric cardiac catheterization. But propofol–ketamine combination was superior to
sevoflurane because the incidence of agitation, nausea and vomiting in patients given sevoflurane
was significantly higher than in ketofol group.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Pediatric cardiac anesthesia involves anaesthetizing very small
children with complex congenital heart disease. The unique
nature of this patient population produces challenges for the
anesthetist because of their altered physiology. The goals of
anesthetic management during cardiac catheterization are
adequate sedation, analgesia, and immobility. The agents used
should have a minimal influence on cardiac function and
respiratory drive [1].
A wide variety of pharmacologic agents and techniques
have been successfully used for these procedures. Sevoflurane
provides the advantage of rapid induction of anesthesia with
short recovery time [2]. Ketofol is a neologism coined to refer
to the combination of ketamine and propofol mixed together
in one syringe. These two drugs are pharmacologically com-
patible [3,4], and this combination has been used widely for
surgical anesthesia. Ketamine and propofol have opposing
influences on blood pressure, heart rate, and systemic vascular
resistance (SVR). In addition, ketamine supplementing a
propofol infusion has been shown to preserve respiratory
function and upper airway control in several studies. There
has been a growing interest in this mixture for anesthesia in
both children [5–10] and adults [11–13], subsequent to reports
of earlier discharge and less vomiting and adverse events after
procedural sedation and analgesia. Propofol total intravenous
anesthesia (TIVA) is an effective and well-tolerated anesthetic
technique that allows smooth induction and rapid recovery,
making it ideal for procedural sedation of children [14–16].
However, approximately 3.7% of children experience
emergence agitation (EA) after propofol TIVA [17,18]. This
frequency is considerably lower than that reported with
sevoflurane (23.1%) [18].
The aim of this study was to compare two anesthetic regi-
mens: sevoflurane and ketofol as maintenance anesthesia in
pediatric patients suffering from congenital heart disease.
The primary outcome was to compare the hemodynamic
effects of sevoflurane and ketofol as maintenance anesthesia.
A significant change more than 20% compared with baseline
values for mean arterial blood pressure was defined as
clinically important. The secondary Outcome was to compare
the side effects and the incidence of agitation on recovery
between the two study groups.
2. Methods
The Alexandria university ethics committee approved the
study, and written informed consent was obtained from
patients’ parents. The study sample included 90 children aging
1 month to 4 years with American Society of Anesthesiologists
grade II to III scheduled for elective cardiac catheterization
between August 2015 and November 2015 in Alexandria
University Hospital. This trial was registered in Pan African
Clinical Trial Registry (PACTR) with identification number
PACTR201605001606658. Patients suffering major endocr-
inal, respiratory, renal or hepatic disorders were excluded.
Patients requiring mechanical ventilation, supplemental oxy-
gen, or intravenous inotropic support were also excluded.
The procedure was performed after a fasting period of 2 h
for clear fluids, 4 h for breast milk and 6 h for light meals.Patients were monitored with electrocardiography, non-
invasive blood pressure measurements, and pulse oximetry.
Baseline blood pressure and heart rate were obtained before
induction. Anesthetic cream was applied to all patients in the
preanesthetic holding area 60 min before the procedure. On
arrival to catheter room a catheter was placed in a peripheral
vein, and lactated Ringer’s solution was infused at the mainte-
nance rate. Blood pressure and heart rate were recorded at
baseline and every 5 min during the procedure. Arterial blood
gases were checked 5 min after insertion of a catheter in the
femoral artery and followed as needed. Induction was accom-
plished with titration of 3–5% sevoflurane, and a peripheral
line was inserted. Patients were randomly assigned using a
table of random numbers and sealed envelope assignment to
one of the two study groups, and group K anesthesia was
induced with ketamine, 1–1.2 mg/kg, and propofol 1–1.2 mg/kg.
Ketofol mixture was prepared in a ratio of 1:2 (50 mg
ketamine diluted with glucose 5% to reach volume of
10 ml + 100 mg propofol 1%, total volume of 20 ml each ml
contain 5 mg propofol +2.5 mg ketamine) infusion rate
propofol 25–50 mic/kg/min and ketamine 12.5–25 mic/kg/min
for maintenance, and 100% oxygen was given through a
tightly fitted face mask. The infusion rate of the propofol
and ketamine mixture was changed according to the required
depth of anesthesia [1]. Group S received sevoflurane 1–2%
according to the required depth of anesthesia in 100% oxygen
for maintenance through a tightly fitted face mask, once the
procedure started. The patients’ groins were infiltrated with
1% lidocaine for femoral vascular access. The anesthetic drugs
were discontinued when the groin bandage was applied.
Parameters were recorded by anesthetist unaware of group
assignment. Changes in mean arterial pressure (MAP) of more
than 20% of awake (baseline) were noted. A vasopressor was
given if a 30% decrease in the resting mean arterial blood pres-
sure for 30 s was noted (1 lg/kg bolus of IV phenylephrine). A
decrease in oxygen saturation of more than 5% from baseline
was also noted. Awakening signs in the patients were moni-
tored according to the modified Steward recovery scoring
system [19] by a blinded researcher who did not participate
in the catheterization procedure in the operating room. The
time to reach a modified Steward score of P6 was recorded.
Agitation was measured postoperatively at 10 min intervals
by a blinded observer using Watcha scale graded as 0 score
(Asleep), 1 score (Calm), 2 score (Crying, but can be consoled),
3 score (Crying, but cannot be consoled), and 4 score (Agitated
and thrashing around) [20]. The incidence of adverse effects
including nausea, vomiting, apnea episodes (apnea was defined
as a pause in breathing for more than 15 s or more than 10 s if
associated with oxygen saturation less than 80%) and
emergence agitation (Watcha scale 3–4) was noted.3. Statistical methods
A power analysis determined that 45 patients per group would
be required to detect 20% reduction in mean arterial blood
pressure with a power of 81% and a significance level of 0.05
using PASS 2000 program [7]
Statistical analysis was done using IBM SPSS statistics
program version 21 and Medcalc program. Quantitative data
were described by mean and median as measures of central
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measures of dispersion, while categorical variables were sum-
marized by frequency and percent. Chi-square test was used
to study significant association between two categorical vari-
ables. Fisher exact and Monte–Carlo tests were used to detect
a difference of more than 20% in quantitative parameters in
the same group of patients. Independent sample t and
Mann–Whitney U-tests were used to detect significant
difference in the mean and median quantitative variables
respectively between two groups of patients.
Repeated measures ANOVA test was done to detect statis-
tical significant difference of mean quantitative variables along
different time periods. We tested homogeneity of variance by
Mauchly’s test of sphericity and Huynh–Feldt test was used
instead of Conventional F test for significant results. Pairwise
comparison was done using adjusted p value after Bonferroni
correction.
All statistical tests were done at .05 significance level.
4. Results
Hundred patients were approached in which 4 were excluded
and 6 parents declined to participate in the current study.
Ninety patients were recruited in this study, 45 in each group
(Fig. 1). There was no statistical difference between the groups
regarding weight, age and, medical illness and procedures
(Table 1). Diastolic blood pressure was significantly lower in
group S in comparison with group K after induction, onFigure 1 The studrecovery and postoperatively. In group K there was significant
decrease in diastolic blood pressure in comparison with base-
line after induction. In Group S there was significant decrease
in diastolic blood pressure in comparison with baseline after
induction as shown in Fig. 2. Systolic blood pressure and heart
rate did not show statistical difference between the study
groups at all measured intervals. Systolic blood pressure in
both groups showed significant decrease in comparison with
base line (Fig. 3). Heart rate did not show statistical difference
between the study groups at all measured intervals. Heart rate
in both groups showed statistically significant increase in com-
parison with baseline (Fig. 4). Need for vasopressor and
decrease in MAP more than 20% compared with baseline
did not show significant difference p(0.832). Recovery time
was statistically shorter in group S p(.000). The incidence of
nausea and vomiting was significantly more in group S p
(.000) (Table 2). Post-operative apnea occurred in 2 patients
in group S p(0.532) in the first hour postoperatively.
Emergence agitation was observed in sevoflurane group in 12
patients p(.000). Watcha scale was significantly lower in group
K at 10 min postoperatively p(.001) (Table 3).
5. Discussion
This study included 90 children with American Society of
Anesthesiologists grade II to III scheduled for elective cardiac
catheterization. We compared two anesthetic regimens:
sevoflurane and ketofol as maintenance anesthesia in pediatricy flow diagram.
Table 1 Demographic data and patients characteristics.
Group K Group S p value
Medical illness
Coarctation 18(40) 19(42.20)
Pulmonary stenosis 11(24.4) 12(26.7)
TGA, VSD, ASD, PDA 16(35.6) 14(31.1) .903
Procedure
PDA closure 5(11.1) 5(11.1)
Diagnostic 16(35.6) 15(33.3)
Ballon valvoplasty 5(11.1) 6(13.33)
Ballon dilatation 11(24.4) 10(22.2)
Atrial septostomy 8(17.7) 9(20) .912
Female 22(48.9) 24(53.3)
Male 23(51.1) 21(46.7) .673
Weight kg 8.51 ± 4.311 7.81 ± 4.735 .465
Age month 15.3248 ± 14.25 11.5142 ± 13.00 .194
Data are presented as number (%) and mean ± SD. Abbreviations: PDA, patent ductus arteriosus; TGA, transposition of great arteries; VSD,
ventricular septal defect; ASD, atrial septal defect.
Figure 2 Diastolic blood pressure in ketofol group and sevoflu-
rane group (mmHg).
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finding of our study was that the incidence of agitation, nausea
and vomiting in patients receiving sevoflurane was significantly
higher than ketofol group and the change of more than 20% in
MAP showed no significant difference between the study
groups.
Watcha scale was significantly lower in group ketofol at
10 min postoperatively p(0.001). Incidences of emergency agi-
tation were significantly higher in sevoflurane group p(0.000).
Emergence agitation is associated with increased morbidity,
hospital costs and delayed discharge. Compared to our results
Chandler et al. examined the incidence of Emergence delirium
in children following sevoflurane (SEVO) anesthesia and
propofol-remifentanil total intravenous anesthesia (TIVA) on
one hundred and twelve children. Incidence of ED was higher
with SEVO (38.3% vs 14.9%, p= 0.018) [21]. In this study the
incidence of nausea and vomiting was significantly more in
group S than in group K. A previous meta-analysis study by
Joo et al. comparing the characteristics of sevoflurane and
propofol for the induction of routine anesthesia concluded that
propofol caused less frequent incidence of postoperative nau-
sea and vomiting [22].
In this study 2 patients suffered from postoperative apnea
episodes in group S, while none of group K suffered from thiscomplication. The difference in the incidence of postoperative
apnea episodes did not reach statistical significance. A
previous study by Davidson et al. compering awake regional
anesthesia (RA) with sevoflurane general anesthesia in young
infants on rates of apnea after anesthesia concluded that RA
in infants reduces apnea in the early postoperative period
[23]. A previous study examining the effects of ketofol versus
propofol on laryngeal mask insertion in children showed pre-
served hemodynamic stability (mean blood pressure, heart
rate) in ketofol group, with less incidence of apnea compared
to Propofol group [24]. A previous study was conducted to
compare side effects of intravenous ketofol on children, and
patients received titrated injection of a solution containing
combination of one part of Ketamine and two parts of
Propofol (1:2) or one part of Ketamine and three parts of
Propofol (1:3). Lower dose of Ketamine in these combinations
has lower psycho mimetic side effects, and shorter recovery
time. Both groups preserved hemodynamic stability and there
was no respiratory depression [25].
Before starting this research work, the authors performed a
pilot study for determination of the optimal proportion and
infusion rate of the propofol–ketamine mixture in children
undergoing cardiac catheterization. A mixture proportion of
5 mg/mL and 2.5 mg/mL and initial infusion rate of
25–50 mic/kg/min and 12.5–25 mic/kg/min of propofol and
ketamine, respectively, were found to provide safe and consis-
tent sedation in this population.
In this study regardless of the significant difference between
the study groups in diastolic blood pressure, the change of
more than 20% in MAP showed no significant difference
between the study groups. The hemodynamic effects of propo-
fol and ketamine are opposed to each other, allowing the use
of lower doses of each agent, reducing their hemodynamic
effects. A previous study conducted by El Din et al. comparing
the combination of ketamine–propofol versus ketamine
fentanyl for anesthesia in children undergoing cardiac
catheterization showed statistical significant decreases in mean
arterial blood pressure (MAP) and systemic vascular resistance
(SVR) in KP group [26]. In agreement with our findings a pre-
vious study conducted by Kogan et al. on forty-five children
aged 6 months to 16 years undergoing cardiac catheterization
Figure 3 Systolic blood pressure in ketofol group and sevoflu-
rane group (mmHg).
Figure 4 Heart rate in ketofol group and sevoflurane group
(Beat/min).
Table 2 Post operative complications.
Group K Group S p value
Need for vasopressor 20(44.4) 19(42.2) .832
MAP change >20% compared
with baseline
23(51.1) 21(46.7) .673
Nausea and vomiting 0(0) 12(26.6) .000*
Apnea 0(0) 2(4.44) 0.532
Recovery time 12.62
± 2.489
6.36
± 1.399
.000*
Emergence delirium 0(0) 12(26.6) .000*
Data are presented as number (%) and mean ± SD. Abbreviation:
MAP, mean arterial pressure.
* Highly significant.
Table 3 Watcha scale.
Group K Group S p value
Watcha scale
At 10 min 1(0–2) 3(1–4) 0.001*
At 20 min 1(1–2) 1(1–2) 0.182
At 30 min 1(1–2) 1(1–2) 0.696
At 40 min 1(1–2) 1(1–2) 0.696
Data are presented as median (minimum–maximum).
* Highly significant.
Ketofol versus sevoflurane for maintenance of aesthesia 253showed that continuous intravenous infusion of a mixture of
propofol and ketamine with spontaneous ventilation provided
hemodynamic stability [1].
Akin et al. investigated the effects of propofol and propo-
fol–ketamine on hemodynamics, sedation level, and recovery
period in pediatric patients undergoing cardiac catheterization.
Propofol combined with low-dose ketamine preserves meanarterial pressure better without affecting the recovery and thus
is a good option in pediatric patients undergoing cardiac
catheterization [7]. A previous study conducted by Russell
et al. on 182 pediatric patients for elective correction or
palliation of congenital heart disease, compares sevoflurane
and halothane maintenance. Patients receiving halothane
experienced twice as many episodes of severe hypotension as
those who received sevoflurane (p= 0.03). Sevoflurane
produces fewer dysrhythmias than halothane [27,28].
The drawback of our study is that we did not correlate the
incidence of emergence agitation with pain using a validated
pain score.
6. Conclusions
Both propofol–ketamine and sevoflurane provided effective
sedation and analgesia during pediatric cardiac catheteriza-
tion. But propofol–ketamine combination was superior to
sevoflurane because the incidence of agitation, nausea and
vomiting in patients given sevoflurane was significantly higher
than in ketofol group.
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